Close

Adaptimmune Therapeutics (ADAP) to Present Updated NY-ESO SPEAR Data at ESMO 2016

Go back to Adaptimmune Therapeutics (ADAP) to Present Updated NY-ESO SPEAR Data at ESMO 2016